+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Contact tracing and antiviral prophylaxis in the early stages of a pandemic: the probability of a major outbreak



Contact tracing and antiviral prophylaxis in the early stages of a pandemic: the probability of a major outbreak



Mathematical Medicine and Biology 32(3): 331-343



Antiviral prophylaxis forms a significant component of health management plans for many countries around the world. A number of studies have shown that the delays typically encountered in distributing these antivirals to households, following the first infectious case, can result in their efficacy being severely reduced. Here, we investigate the use of contact tracing as a method to reduce the delays and hence mitigate the reduction in efficacy of antivirals. We assess the usefulness of contact tracing in terms of the probability of a major outbreak. It is found, with parameter distributions appropriate to the 2009 H1N1 pandemic and distributions reflecting commonly experienced delays, that standard contact tracing renders an outbreak impossible approximately one in five times compared with approximately one in ten times in its absence. A contact-tracing efficiency of 50% would see further improvements with an outbreak being impossible approximately one in four times, and a reduction of the median probability of a major outbreak from 0.41 to below 0.27.

(PDF emailed within 0-6 h: $19.90)

Accession: 052316493

Download citation: RISBibTeXText

PMID: 25228290

DOI: 10.1093/imammb/dqu014


Related references

Effectiveness of antiviral prophylaxis coupled with contact tracing in reducing the transmission of the influenza A (H1N1-2009): a systematic review. Theoretical Biology & Medical Modelling 10(): 4-4, 2013

Estimating the probability of a major outbreak from the timing of early cases: an indeterminate problem?. Plos One 8(3): E57878-E57878, 2013

Antiviral prophylaxis and isolation for the control of pandemic influenza. International Journal of Environmental Research and Public Health 11(8): 7690-7712, 2015

Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios. Bmc Public Health 15(): 190-190, 2015

A/H1N1 flu pandemic. Antiviral drugs: distinguish treatment from prophylaxis. Bmj 339: B3620-B3620, 2009

Antiviral prophylaxis during pandemic influenza may increase drug resistance. Bmc Infectious Diseases 9(): 4-4, 2009

Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic. Mathematical Biosciences 209(2): 336-360, 2007

Contact Tracing during an Outbreak of Ebola Virus Disease in the Western Area Districts of Sierra Leone: Lessons for Future Ebola Outbreak Response. Frontiers in Public Health 4: 130-130, 2016

When is contact tracing not enough to stop an outbreak?. Lancet. Infectious Diseases 18(12): 1302-1304, 2018

Epidemiological consequences of household-based antiviral prophylaxis for pandemic influenza. Journal of the Royal Society, Interface 10(81): 20121019-20121019, 2013

Estimating the Tracing Probability from Contact History at the Onset of an Epidemic. Mathematical Population Studies 14(4): 211-236, 2007

Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States. Emerging Infectious Diseases 17(9): 1591-1598, 2012

Contact tracing and prophylaxis of tuberculosis. Ugeskrift for Laeger 173(12): 883-886, 2011

A hospital-based strategy for setting priorities for antiviral prophylaxis during an influenza pandemic. Biosecurity and Bioterrorism 6(2): 171-178, 2008

Role of contact tracing in containing the 2014 Ebola outbreak: a review. African Health Sciences 17(1): 225-236, 2017